Revolution Medicines Overview
Revolution Medicines Target Price
Analysts' 12-month price predictions for RVMD.
Share Price
$41.09
Average Target Price
$68.00
65.5% upside
65.5% upside2 analysts in the last 4 months
High: $72 | Low: $64
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-14 | H.C. WainwrightRobert Burns | $72 | 75.2% upside |  |
| 2025-04-01 | Stifel NicolausBenjamin Burnett | $64 | 55.8% upside | |
| 2025-01-08 | UBSEliana Merle | $71 | 72.8% upside | |
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $70 | 70.4% upside | |
| 2024-11-04 | H.C. WainwrightRaghuram Selvaraju | $62 | 50.9% upside | |
| 2024-10-28 | GuggenheimMichael Schmidt | $82 | 99.6% upside | |
| 2024-10-28 | OppenheimerJay Olson | $60 | 46% upside | |
| 2024-10-15 | OppenheimerJay Olson | $55 | 33.9% upside | |
| 2024-09-17 | Piper SandlerJoseph Catanzaro | $57 | 38.7% upside | |
| 2024-08-08 | NeedhamAmi Fadia | $61 | 48.5% upside | |
| 2024-07-15 | WedbushRobert Driscoll | $59 | 43.6% upside | |
| 2024-04-19 | Stifel NicolausBen Burnett | $43 | 4.6% upside | |
| 2024-04-12 | NeedhamAmi Fadia | $46 | 11.9% upside | |
| 2024-04-12 | OppenheimerJay Olson | $45 | 9.5% upside | |
| 2024-04-10 | Raymond JamesLaura Prendergast | $48 | 16.8% upside | |
| 2023-11-16 | Raymond JamesDane Leone | $30 |  27% downside | |
| 2022-12-14 | Needham | $31 | 24.6% downside | |